fda glp-1 compounding warning letters september 2025 U.S. sends drug advertising to Lilly, Novo, Hims FDA Moves to Restrict Mass-Marketed

Packaging by weight, not by volume

While neuroinflammation occurs in ALS patients independent of the cause of the disease and thus should be a shared target, it is however likely that patients will respond differently to certain therapies depending on their progression rate and disease state when receiving the treatment

Unlike GLS1, GLS2 is not inhibited by CB-839 or glutamate (its immediate byproduct), and can directly bind and inhibit Rac1 (Ras-related C3 botulinum toxin substrate 1), suppressing murine and human hepatocellular carcinoma cells migration and metastasis in a mouse model [205]

GLP-1 medications should be stopped if pancreatitis develops, and should likely be avoided in anyone with pre-existing gastroparesis

Are compounded GLP-1s safe after the February 2026 FDA warning letters

However, the type of oral supplementation you choose will make a big difference in therapeutic effects